RDY · Dr Reddys Laboratories Ltd
$11.80
-0.01 (-0.04%)
At close · Jul 24
Market Cap
$9.82B
Shares
833.00M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-12-18 | MEHTA SANJIV SOSHIL |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | KUMAR ARUN MADHAVAN |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | KODUMUDI PRANATHARTHI HARAN KRISHNAN |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | SHARMA SHIKHA SANJAYA |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | Seth Alpna |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | VENKATESH KRISHNA |
Global Head - IPDO |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | PURI LEO |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | Israeli Erez |
CHIEF EXECUTIVE OFFICER |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-18 | WAN PENNY CHAN |
Director |
Other↑
|
No Securities Owned
|
0 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–9 of 9 transactions
Key facts
CIK
1135951
CUSIP
256135203
13F (30d)
45 filings
45 filers
Visit website
Investor relations